Is CCRIS 574 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use CCRIS 574? Is CCRIS 574 safe for nursing mother and child? Does CCRIS 574 extracts into breast milk? Does CCRIS 574 has any long term or short term side effects on infants? Can CCRIS 574 influence milk supply or can CCRIS 574 decrease milk supply in lactating mothers?
CCRIS 574 lactation summary
- DrLact safety Score for CCRIS 574 is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of CCRIS 574 may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that CCRIS 574 may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of CCRIS 574 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using CCRIS 574 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About CCRIS 574 usage in lactation
CCRIS 574 hormone reduces Prolactin serum levels and may likely inhibit milk production mainly soon after delivery. No significant increase of CCRIS 574 serum levels neither in the mother´s milk nor in the infant’s serum have been found after administration to the mother. No adverse side effects have been noticed in the infant.
Answer by DrLact: About CCRIS 574 usage in lactation
Limited data indicate that a low-dose (100 mg) subcutaneous CCRIS 574 pellet given to a nursing mother appears not to increase milk CCRIS 574 levels markedly. CCRIS 574 has low oral bioavailability because of extensive first-pass metabolism, so it is unlikely to affect the breastfed infant. One breastfed infant seemed not to be adversely affected by low-dose maternal CCRIS 574 therapy.
CCRIS 574 Side Effects in Breastfeeding
An infant (age not stated) was breastfed (extent not stated) after implantation of 100 mg of CCRIS 574 subcutaneously. No adverse effects were noted in the infant over a 5-month period.[1]
CCRIS 574 Possible Effects in Breastfeeding
Supraphysiologic serum levels of CCRIS 574, either from a tumor[2][3] or from exogenously administered CCRIS 574,[4] reduces milk production in postpartum women. CCRIS 574 alone reduces serum prolactin;[4] however, when given in combination with estrogen and progestin, serum prolactin levels are not markedly reduced.[5] CCRIS 574 was previously used therapeutically to suppress lactation, usually in combination with an estrogen.[4][5][6][7][8][9][10]
Alternate Drugs
Testosterone(Low Risk)
Estradiol(Low Risk)
Estradiol Valerate(Low Risk)
Testosterone(Low Risk)
Progesterone(Safe)